Advanced search
Publication Cover
Vascular Health and Risk Management Volume 5, 2009 - Issue
Submit an article Journal homepage
78
Views
3
CrossRef citations to date
0
Altmetric
Review

Role of aliskiren in cardio-renal protection and use in hypertensives with multiple risk factors

Eduardo Pimenta1 Endocrine Hypertension Research Center and Clinical Center of Research Excellence in Cardiovascular Disease and Metabolic Disorders, University of Queensland School of Medicine, Princess Alexandra Hospital, Brisbane, QLD, AustraliaCorrespondence[email protected]
&
Suzanne Oparil2 Vascular Biology and Hypertension Program, University of Alabama at Birmingham, Birmingham, AL, US
Pages 453-463 | Published online: 19 May 2009

Citations (3)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Benjamin J Epstein, Paul T Leonard & Niren K Shah. (2012) The evolving landscape of RAAS inhibition: from ACE inhibitors to ARBs, to DRIs and beyond. Expert Review of Cardiovascular Therapy 10:6, pages 713-725.
Read now
Graziano Riccioni, Nicola Vitulano, Alessandra Zanasi, Fulvio Bellocci & Nicolantonio d'Orazio. (2010) Aliskiren: beyond blood pressure reduction. Expert Opinion on Investigational Drugs 19:10, pages 1265-1274.
Read now

Articles from other publishers (1)

Olga Pechanova, Andrej Barta, Martina Koneracka, Vlasta Zavisova, Martina Kubovcikova, Jana Klimentova, Jozef Tӧrӧk, Anna Zemancikova & Martina Cebova. (2019) Protective Effects of Nanoparticle-Loaded Aliskiren on Cardiovascular System in Spontaneously Hypertensive Rats. Molecules 24:15, pages 2710.
Crossref

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.